Drug intelligence / Profile preview

(R,R)-penehyclidine fumarate

Development stage
Unknown
Lead developer
Beijing Institute of Pharmacology and Toxicology
Modality
Small Molecules
Administration
Intramuscular, Intravenous
01

Overview

(R,R)-penehyclidine fumarate is a potent, long-acting anticholinergic agent and the most pharmacologically active stereoisomer of penehyclidine. Developed by the Institute of Toxicology and Pharmacology at the Academy of Military Medical Sciences in China, it functions as a selective antagonist of M1 and M3 muscarinic receptors and nicotinic receptors, while exhibiting significantly lower affinity for M2 receptors. This selectivity profile is designed to provide effective inhibition of glandular secretions and smooth muscle relaxation without the significant tachycardia often induced by non-selective anticholinergics like atropine. It is primarily utilized as a pre-anesthetic medication to inhibit secretions and as a treatment for organophosphate nerve agent poisoning.

Other names
(R,R)-penehyclidine fumaratepenehyclidine fumarate
02

Targets

CHRM3 (M3)M1 (Muscarinic acetylcholine receptor M1)

Beyond the preview

Go deeper on (R,R)-penehyclidine fumarate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (R,R)-penehyclidine fumarate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call